In the Boardroom
Refine Search
Biotechnology
US RNA (mRNA) therapeutics and vaccines specialist Moderna today announced that Ray Jordan has joined the firm as chief corporate affairs officer, effective Monday, June 15, 2020. 16 June 2020
Pharmaceutical
Mundipharma today announced that Marc Princen has joined the Mundipharma network of independently associated companies as the global chief executive, effective June 1, 2020. 15 June 2020
Pharmaceutical
As part of an R&D overhaul, Copenhagen-based CNS specialist Lundbeck has announced plans to reduce its headcount by around 150, mostly in Denmark. 9 June 2020
Generics
Swiss company Lonza has named Pierre-Alain Ruffieux its new chief executive. 8 June 2020
Biotechnology
Privately-held German firm Immatics Biotechnologies today announced that Cedrik Britten has been appointed as chief medical officer (CMO) effective June 1, 2020. 4 June 2020
Biotechnology
Life sciences venture capital firm Forbion says that its newest portfolio company, Prilenia Therapeutics, a Naarden, Netherlands- and Herzliya, Israel-based clinical stage biotech company, has raised $62.5 million in a Series A financing round. 4 June 2020
Biotechnology
Clinical-stage USA-based biotech Aruvant Sciences today announced the appointment of V "Palani" Palaniappan, as chief technology officer (CTO) effective immediately. 1 June 2020
Biotechnology
French drugmaker Ipsen, which has been under interim management since the surprise departure of its chief executive David Meek in December last year, today announced it has appointed David Loew as its new CEO and as board member. The CEO appointment will take effect on July 1, 2020 29 May 2020
Biotechnology
Less than two year after engaging a new head of the company, Stockholm, Sweden-based biotech Medivir has appointed a new chief executive, namely Yilmaz Mahshid. 26 May 2020
Biotechnology
Privately-held Galecto has added some boardroom experience in the shape of Amit Munshi, the chief executive of Arena Pharmaceuticals, and David Shapiro, the former chief medical officer of Intercept Pharmaceuticals. 20 May 2020
Biosimilars
Biosimilars specialist Alvogen has named Tanya Zharov its new deputy chief executive, based in Iceland. 18 May 2020
Pharmaceutical
On Friday, US President Donald Trump announced the addition of two of the most highly respected and skilled professionals to the White House new initiative, dubbed Operation Warp Speed, the objective of which is to finish developing and then to manufacture and distribute a proven coronavirus vaccine as fast as possible. 16 May 2020
Pharmaceutical
Swiss pharma giant Roche today announced that, on May 10, Dr Fritz Gerber, a formative figure in the company’s history, died in his 92nd year. 11 May 2020
Pharmaceutical
New Jersey, USA-based rare disease drug developer PTC Therapeutics today announced the appointments of Matthew Klein to chief development officer and Eric Pauwels to chief business officer. 17 April 2020
Biotechnology
Oxford BioDynamics, a UK biotech focused on the discovery and development of biomarkers, based on regulatory 3D genome architecture, using its liquid biopsy platform EpiSwitch, announces that Dr Jon Burrows has been appointed as group chief executive, effective 23 March 2020. 16 March 2020
Biotechnology
German newspaper Welt am Sonntag over the weekend said that US President Donald Trump “had offered funds” to entice German mRNA-based drug specialist CureVac to move its recently started COVID-19 R&D work to the USA, and the German government was now “making counter-offers to tempt it to stay.” 16 March 2020
Biotechnology
Akcea Therapeutics, a majority-owned affiliate of Ionis Pharmaceuticals, today announced that Lisa Johnson-Pratt has joined the company as senior vice president of new product strategy. 11 March 2020
Biotechnology
Horama, the ophthalmic gene therapy company, has named Rodolphe Clerval as its chief business officer. 11 March 2020
Generics
Germany’s Stada Arzneimittel says it is now the largest foreign investor in the Russian pharmaceutical industry, following the completion of a $660 million transaction for a Russian brand portfolio from Japan’s Takeda. 5 March 2020
Biotechnology
Swedish biotech Cantargia has appointed Dr Ignacio Garcia-Ribas as chief medical officer (CMO) of Cantargia effective March 1, 2020 26 February 2020
Biotechnology
US biotech Paragon Therapeutics yesterday revealed that biotech industry veteran Susanna High has been appointed as chief executive (CEO). In this newly-created role, Ms High will lead the team’s continued efforts to propel the development of a pipeline of transformative therapies and accelerate their potential impact. 22 November 2024
Biotechnology
US biotech major Amgen has announced that Dr Howard Chang will join the company as senior vice president of research, effective December 16, 2024. 21 November 2024
Pharmaceutical
Anthony Harnden has been appointed as the new chair of the UK’s Medicine and Healthcare products Regulatory Agency (MHRA). 20 November 2024
Biotechnology
Mirai Bio has announced the appointment of Jens Vogel as the company’s president and chief operating officer (COO). 20 November 2024
Biotechnology
Aclaris Therapeutics has announced an exclusive licensing agreement with Biosion for broad rights to two new antibodies. 19 November 2024
Biotechnology
Privately-held US biotech Georgiamune has announced the appointment of Mark Avagliano as chief business officer (CBO). 19 November 2024
Pharmaceutical
New York-based Mind Medicine, a company developing MM120, a form of LSD (lysergide d-tartrate), for mental health conditions, has announced the appointment of Gregg Pratt, as chief regulatory and quality assurance officer. 19 November 2024
Biotechnology
Belgian biotech start-up ExeVir Bio says it has appointed Michael Garrett as its new chief executive (CEO), effective 1 December 2024. 18 November 2024
Biotechnology
ALX Oncology Holdings, a Californian immuno-oncology company, has announced the appointment of Alan Sandler as chief medical officer (CMO). 14 November 2024
Pharmaceutical
US ophthalmology specialist Ocular Therapeutix announced that Namrata Saroj has joined the Company on a full-time basis as chief business officer (CBO). Dr Saroj previously served as development strategy consultant to Ocular since February 2024. 14 November 2024
Biotechnology
VarmX, a Dutch biotech developing innovative approaches for the bypass of direct oral anticoagulants targeting activated factor Xa (FXa DOACs) and inherited coagulation disorders, has appointed industry veteran John Glasspool (pictured, above) as chief executive. 12 November 2024
Biotechnology
French biotech DiogenX, which is focused on regenerating insulin-producing beta cells for the treatment of diabetes, today announces the appointment of Dr Klara Owen as chief medical officer. 12 November 2024
Biotechnology
Rubedo Life Sciences, a US biopharma developing first-in-class therapies targeting senescent cells which drive age-related diseases, has announced the appointment of Frederick C Beddingfield III, as chief executive officer and board director. 11 November 2024
Biotechnology
US clinical-stage drug developer Acumen Pharmaceuticals has appointed Amy Schacterle as chief regulatory officer and head of quality, reporting to Jim Doherty, president and chief development officer at Acumen. 7 November 2024
Biotechnology
Memo Therapeutics, a privately-held Swiss biotech company translating unique responses into superior medicines to treat viral infections and cancer, has appointed a new chief development officer (CDO). 4 November 2024
Biotechnology
Netherlands-based Tessellate BIO, a pre-clinical stage biotech with a focus on novel synthetic lethality approaches, today announced the appointment of Dr Lara Boyd as chief business officer. 4 November 2024
Biotechnology
US biotech major Biogen revealed it has appointed Daniel Quirk as chief medical officer and head of medical affairs. 29 October 2024
Pharmaceutical
Fennec Pharmaceuticals has announced the addition of three new executives to bolster its leadership team as the company prepares for expanded commercial operations. 28 October 2024
Biotechnology
AAVantgarde has announced the appointment of Lauren Kaskiel as chief business officer (CBO). 22 October 2024
Sign up to receive email updates
Join industry leaders for a daily roundup of biotech & pharma news
Today's issue
Company Spotlight
A US biotech company dedicated to creating oral drugs with an emphasis on indications in virology and immunology.
Copyright © The Pharma Letter 2024 | Headless Content Management with Blaze